Drug Profile


Alternative Names: CERM 4205; ORG 30701

Latest Information Update: 31 Dec 1995

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Akzo Nobel
  • Developer Akzo Nobel; Organon
  • Class Anti-ischaemics; Ischaemic heart disorder therapies; Small molecules
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Angina pectoris; Arrhythmias

Most Recent Events

  • 31 Dec 1995 Discontinued-II for Angina pectoris in France (IV-injection)
  • 31 Dec 1995 Discontinued-II for Angina pectoris in France (PO)
  • 31 Dec 1995 Discontinued-II for Arrhythmias in France (IV-injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top